Information about Gelaphar
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0426.709.631

VAT liability
Yes
Established
01-01-1985
Last balance sheet year
2024
Company size
Small 1,2 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Gelaphar

2024 2023 2022 2021
Profit/Loss 60,606 6 % 57,002 -28 % 79,087 5 % 75,657
Equity 371,921 19 % 311,315 22 % 254,312 -8 % 275,225
Gross margin 207,827 19 % 174,801 -15 % 205,506 10 % 186,592
Employees 1.2 1.4 1.6 1.7

Publications from Gelaphar

Date Publication
03-04-2024 Articles of Association (Translation, Coordination, Other Modifications,...) (FR)
25-08-2009 Registered Office - Resignations - Appointments (NL)
06-12-2006 Resignation(s) Appointment(s) (NL)
21-08-2006 Modification(s) Articles of Association (NL)
05-10-1999 Modification(s) Articles of Association Translation Articles of Association (FR)

Frequently asked questions

What is the VAT number of Gelaphar?
The VAT number of Gelaphar is BE 0426.709.631.
Wat is the PEPPOL ID of Gelaphar?
The PEPPOL ID of Gelaphar is 0208:0426709631. Log in or start a free trial to see the full overview.
When was Gelaphar founded?
Gelaphar was founded on 01-01-1985.
What is the address of Gelaphar?
The current registered office of Gelaphar is located at Kloosterstraat 7, 3798 Voeren.
When was the last time Gelaphar filed their annual financial statements?
The most recent financial statements of Gelaphar were filed on 01-07-2025.
How many employees does Gelaphar have?
There are 1,2 FTEs working at Gelaphar according to the staff figures in the most recent financial statements.
What is the annual turnover of Gelaphar?
At the time of its most recent financial statements, Gelaphar did not publish any turnover figures. Gelaphar reported a gross margin of €207,827.34.